Novolight DX
Hematological Analysis Devices
Health Tech & Life Sciences
Non Active, Aug 2025 ceased to operate
Company Overview
Snapshot
Founded in June 2023 by Ben Leshem and Ittai Madar, Novolight DX operates with 1–10 employees. The company secured its seed funding in January 2024, receiving a grant from the Israel Innovation Authority.
Business overview
Novolight DX is a Health Tech & Life Sciences company focused on developing hematological analysis devices. The company's core technology is in the R&D phase, aiming to serve the healthcare and life sciences sectors, specifically targeting providers and laboratories with its B2B business model.
Company Intelligence Q&A
- When was Novolight DX founded?
- Novolight DX was founded in June 2023.
- Who are the founders of Novolight DX?
- The co-founders of Novolight DX are Ben Leshem and Ittai Madar.
- What is Novolight DX's primary sector?
- Novolight DX operates primarily in the Health Tech & Life Sciences sector, with a focus on Medical Devices and Diagnostics Devices.
- What is the current employee count for Novolight DX?
- Novolight DX currently has 1–10 employees.
- What is the status of Novolight DX?
- Novolight DX is currently Non Active, having ceased to operate in August 2025.